The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: Treatment outcome and prognostic factor analysis.
Youwu Shi
No relevant relationships to disclose
Yuankai Shi
No relevant relationships to disclose
Shengyu Zhou
No relevant relationships to disclose
Xiaohui He
No relevant relationships to disclose
Xiaohong Han
No relevant relationships to disclose
Shikai Wu
No relevant relationships to disclose
Feng Pan
No relevant relationships to disclose
Peng Liu
No relevant relationships to disclose
Yinyu Liu
No relevant relationships to disclose
Yingheng Lei
No relevant relationships to disclose
Hongzhi Zhang
No relevant relationships to disclose
Jianliang Yang
No relevant relationships to disclose
Yan Qin
No relevant relationships to disclose
Changgong Zhang
No relevant relationships to disclose
Sheng Yang
No relevant relationships to disclose
Liya Zhao
No relevant relationships to disclose
Kehuan Luo
No relevant relationships to disclose
Guanqing Wu
No relevant relationships to disclose
Yan Sun
No relevant relationships to disclose